Aprameya EngineeringNSE:APRAMEYA -1.46%50 PS Ratio is 5.01 as of Jul. 08, 2026, which is 68% above its 10-year median of 2.99. GuruFocus rates NSE:APRAMEYA with a GF Score™ of 50/100. The stock has 6 warning signs investors should review. Among 804 Medical Devices & Instruments companies, Aprameya Engineering ranks worse than 69.15% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Aprameya Engineering's share price is ₹145.10.
Aprameya Engineering's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ₹28.96. Hence, Aprameya Engineering's PS Ratio for today is 5.01.
The historical rank and industry rank for Aprameya Engineering's PS Ratio or its related term are showing as below:
NSE:APRAMEYA'
s PS Ratio Range Over the Past 10 Years
Min: 1.22 Med: 2.99 Max: 8.17
Current: 5.02
During the past 7 years, Aprameya Engineering's highest PS Ratio was 8.17. The lowest was 1.22. And the median was 2.99.
NSE:APRAMEYA's PS Ratio is ranked worse than 69.15% of 804
companies
in the Medical Devices & Instruments industry
Industry Median: 2.935
vs NSE:APRAMEYA: 5.02
Aprameya Engineering Ltd revenue per share has been in decline over the past 3 years.
During the past 12 months, the average Revenue per Share Growth Rate of Aprameya Engineering was -62.90% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -11.00% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 8.00% per year.
During the past 7 years, Aprameya Engineering's highest 3-Year average Revenue per Share Growth Rate was 85.50% per year. The lowest was -11.00% per year. And the median was 13.30% per year.
Back to Basics: PS Ratio
Aprameya Engineering (NSE:APRAMEYA) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Aprameya Engineering PS Ratio Related Terms
Aprameya Engineering PS Ratio Historical Data
* Premium members only.
The historical data trend for Aprameya Engineering's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:APRAMEYA vs ISRG, BDX, MDLN: PS Ratio Comparison
For the Medical Instruments & Supplies subindustry, Aprameya Engineering's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aprameya Engineering PS Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Aprameya Engineering's PS Ratio distribution charts can be found below:
* The bar in red indicates where Aprameya Engineering's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Aprameya Engineering's Share Price of today is ₹145.10.
For company reported annually, GuruFocus uses latest annual data as the TTM data. Aprameya Engineering's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ₹28.96.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Aprameya Engineering (NSE:APRAMEYA) has a PS Ratio of 5.01 as of Jul. 08, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Aprameya Engineering and its competitors. This is 68% above median its historical median of 2.99. Over the past decade, Aprameya Engineering's PS Ratio has ranged from 1.22 to 8.17. According to the industry distribution chart, Aprameya Engineering ranks #556 out of 804 companies in the Medical Devices & Instruments industry, placing it in the top 69.2%.
Is Aprameya Engineering's PS Ratio too high?
Aprameya Engineering's current PS Ratio of 5.01 is 68% above median its 10-year median of 2.99. Over the past 10 years, this metric has ranged from a low of 1.22 to a high of 8.17. The Medical Devices & Instruments industry median PS Ratio is 2.94. Aprameya Engineering's value of 5.01 is 70.7% above this industry median. Based on the distribution chart, Aprameya Engineering ranks #556 out of 804 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Aprameya Engineering has a GF Score™ of 50/100, reflecting its overall financial health beyond just this single metric.
How does Aprameya Engineering's PS Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Aprameya Engineering ranks #556 out of 804 companies for PS Ratio. This places Aprameya Engineering in the lower half of its industry. The industry median PS Ratio is 2.94. Aprameya Engineering's value of 5.01 is 70.7% above this benchmark. Historically, Aprameya Engineering's own PS Ratio has ranged from 1.22 to 8.17 over the past decade. While the company's 10-year median is 2.99 vs. the industry median of 2.94, Aprameya Engineering has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Devices & Instruments company?
The median PS Ratio among Medical Devices & Instruments companies is 2.94, based on 804 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aprameya Engineering's current PS Ratio of 5.01 is 70.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Aprameya Engineering and its competitors. For the Medical Devices & Instruments industry, the median PS Ratio is 2.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aprameya Engineering's current PS Ratio is 5.01, which is 68% above median its own 10-year median of 2.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aprameya Engineering stock overvalued right now?
Aprameya Engineering (NSE:APRAMEYA) has a current PS Ratio of 5.01. The current PS Ratio is 5.01, which is 68% above median its 10-year median of 2.99 and 70.7% above the Medical Devices & Instruments industry median of 2.94. Aprameya Engineering's overall GF Score™ is 50/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Aprameya Engineering (NSE:APRAMEYA), the current PS Ratio is 5.01 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Aprameya Engineering Ltd is engaged in the business of installation, set up & maintenance of Intensive Care Units (ICU), Neonatal Intensive Care Units (NICU), Pediatric Intensive Care Units (PICU), Operation Theatre, dialysis centres and prefabricated structure ward (hereinafter referred to as Healthcare Infrastructure projects) in the hospitals and medical care centers on turnkey basis with the supply of high-value healthcare equipment and diagnostic equipment to private hospitals, Government hospitals, and medical practitioners. The company has two Business segments: Trading of Medical support Equipment (Trading Sales) and Supplies for Infra Projects for health care sectors (Turnkey project supplies). Key revenue is generated from Trunkey Project Supply.
50GF Score
Get the complete analysis for NSE:APRAMEYA
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:APRAMEYA has been successfully added to your 